The FDA announced approval of the first gene therapy for leukemia. From pharmaceutical giant Novartis, in collaboration with University of Pennsylvania’s Perelman School of Medicine, clinical trials, based on research funded by ACGT, resulted in 83% remission for pediatric patients with acute lymphocytic leukemia [ALL]. Read More
STAMFORD, Conn., July 12, 2017 — Today the FDA’s Oncologic Drugs Advisory Committee, an independent panel of experts, voted unanimously to recommend to the FDA … Read More
On Saturday, June 24, 2017, more than 300 swimmers made waves in the fight to defeat cancer at the 11th annual Swim Across America Greenwich-Stamford … Read More
I have always considered myself to be a very lucky person, but I wasn’t feeling very lucky the day I was told I had chronic … Read More
In 2012, Bob Levis, an Allentown, Pennsylvania resident, believed he had come to the end of his life. Diagnosed in 2002 with chronic lymphocytic leukemia, … Read More
“They took my cancer cells and irradiated them, and then injected them back into my body so my immune system would kick in,” Morrow said. Read More
Alliance for Cancer Gene Therapy fellow, Dr. Samuel Katz at Yale Medical Center, speaks about cell and gene therapies for cancer treatment. There has been … Read More
Dr. Stephen Eck, Member of Alliance for Cancer Gene Therapy’s Scientific Advisory Council, talks about the importance of personalized therapies for cancer. “Historically, we’ve tried … Read More
Dr. Michael Lotze, Member of Alliance for Cancer Gene Therapy’s Scientific Advisory Council speaks about progress in the fight against cancer he has witnessed during his … Read More
The mission of ACGT is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.
Cell and gene therapies are destroying tumors every day in the laboratory and in human trials, targeting only the cancer with few side effects to healthy tissue. ACGT’s rigorous grant review process, under the guidance of a preeminent Scientific Advisory Council, have resulted in some of the most successful breakthroughs in the history of cancer treatments and led to many patients in complete remission.
100% of our funding supports innovation and translational science that is proving again and again to offer better treatment options than the traditional therapies of chemotherapy, surgery and radiation. Every donation brings us closer to saving lives and changing the way we treat cancer forever.
